Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Bayside, New York Clinical Trials

A listing of Bayside, New York clinical trials actively recruiting patient volunteers.

RESULTS

Found (25) clinical trials

A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis

The purpose of this study is to evaluate the efficacy and safety of mirikizumab as maintenance therapy in participants who completed prior 12-week induction study AMAN (NCT03518086).

Phase

2.63 miles

Learn More »

Did you know heart disease is the number one killer of women in the United States? Take the first step toward prevention by participating in a heart screening to better understand your risk, and by doing so, have the potential to help establish a clearer tool to look for heart ...

Phase N/A

4.83 miles

Learn More »

Did you know heart disease is the number one killer of women in the United States? Take the first step toward prevention by participating in a heart screening to better understand your risk, and by doing so, have the potential to help establish a clearer tool to look for heart ...

Phase N/A

4.83 miles

Learn More »

A Study of Zanubrutinib (BGB-3111) Versus Ibrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia

This is a global, Phase 3, randomized study of zanubrutinib versus ibrutinib in approximately 400 patients with relapsed/refractory chronic lymphocytic leukemia or small lymphocytic lymphoma. The primary efficacy endpoint is overall response rate determined by independent central review. Patients will be randomized in a 1:1 manner to either zanubrutinib or ...

Phase

4.83 miles

Learn More »

Abiraterone With Discontinuation of Gonadotropin-Releasing Hormone Analogues in Metastatic Prostate Cancer

Abiraterone inhibits the CYP17A enzyme, which is a critical enzyme in androgen biosynthesis. Abiraterone has regulatory approval in metastatic castration-resistant prostate cancer (mCRPC) in both chemotherapy-nave and in the post-docetaxel setting based upon results from two randomized phase III studies. Abiraterone is also proven to extend survival in the metastatic, ...

Phase

5.01 miles

Learn More »

Coherence Imaging of the Cervical Epithelium With Scanning a/LCI

The purpose of this study is to develop a low coherence interferometry (LCI) endoscopic probe that can examine the cervix for evidence of cervical dysplasia. The device will make optical measurements of the cervix to determine: the difference between two different types of cervical cells: ectocervical cells and endocervical cells. ...

Phase N/A

5.01 miles

Learn More »

Chronic leg ulcers are a serious complication of Sickle Cell Disease, in which red blood cells break down earlier than normal and can stick to vessel walls, causing a blockage that slows or stops the flow of blood. Current therapies are not very effective and often leg ulcers take months ...

Phase

5.01 miles

Learn More »

Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy

B7451029 is a Phase 3 study to investigate PF-04965842 in adult patients who have moderate to severe atopic dermatitis and use background topical therapy. The efficacy of two dosage strengths of PF-04965842, 100 mg and 200 mg taken orally once daily will be evaluated relative to placebo over 12 weeks. ...

Phase

6.08 miles

Learn More »

A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis

The purpose of this study is to compare the efficacy and safety of ixekizumab to guselkumab in participants with moderate-to-severe plaque psoriasis.

Phase

6.08 miles

Learn More »

Study of VTS-270 (2-hydroxypropyl- -cyclodextrin) to Treat Niemann-Pick Type C1 (NPC1) Disease

Non-clinical studies and a Phase 1 clinical trial suggest that intrathecal administration of 2-hydroxypropyl- -cyclodextrin (VTS-270) in patients with neurologic manifestations of Niemann-Pick Type C1 (NPC1) disease has the potential to slow the rate of progression of their neurologic disease. Niemann-Pick Type C1 (NPC1) disease is a rare, neurodegenerative, inherited, ...

Phase

7.46 miles

Learn More »